Select language:  
1800 620 420
Close menu

Research in action

All the latest research news and breakthroughs.

Subscribe to hear more from the Leukaemia Foundation.

The importance of molecular response in CML

Dr Susan Branford's research involved assessing people with CML to determine if monitoring the level of disease during therapy using a molecular marker could predict treatment outcome.

  • Chronic myeloid leukaemia
  • Research
Read more
Professor Susan Branford

Latest ALLG clinical trials recruiting for AML

Four clinical trials run by the Australasian Leukaemia & Lymphoma Group* (ALLG) are currently open to a range of people with acute myeloid leukaemia (AML) across Australia.

  • Acute myeloid leukaemia
  • Research
Read more
Professor Andrew Wei

New 3D models could revolutionise drug testing

Dr Laura bray hopes her work will provide answers to the many unknowns faced by people with AML.

  • Acute myeloid leukaemia
Read more
Dr Laura Bray in the lab 2

Why Dr Morrison pays attention to his vitamin C intake

Internationally recognised leader in stem cell research, Dr Sean Morrison, makes sure he gets his daily requirement of vitamin C – not a lot more and definitely no less!

  • Acute myeloid leukaemia
  • Research
Read more
Dr Sean Morrison

Dr Traver’s fascination with how leukaemia happens

Dr David Traver is an experimental haematologist who specialises in haematopoiesis.

  • Acute myeloid leukaemia
  • Research
Read more
Dr David Traver

Developing mutation-specific targeted therapies for AML – “a new era of medicine has begun”

Dr Daniel Thomas brought us up-to-speed on his multi-faceted work in the field of myeloid leukaemia.

  • Acute myeloid leukaemia
  • Research
Read more
A/Prof Dan Thomas

Deborah’s one of the first Aussies to have CAR T-cell therapy for CLL

Thirty-one days after Deborah Sims had an infusion of her own re-engineered T-cells in September, she was told her aggressive CLL was in remission and she may well be cured.

  • Chronic lymphocytic leukaemia
Read more
Deborah Sims and children

Expert Series interview with Professor Constantine Tam on CLL–now and into the future

We spoke to Professor Con Tam on the latest in CLL research.

  • Chronic lymphocytic leukaemia
  • Research
Read more
Professor Constantine Tam

Familial research key to blood cancer prevention strategy

The Australian Familial Haematological Cancer Study (AFHCS) leads the world in the field and has a research cohort of more than 200 families with a history of blood cancer.

  • Acute myeloid leukaemia
  • Myelodysplastic syndromes
  • Research
Read more
AFHCS research team

PhD scholarships focused on improving outcomes for people with AML and MPN

Basit Salik, Dr Jamie Kuzich and Dr Julian Grabek are the successful recipients of the 2021 PhD Scholarships.

  • Acute myeloid leukaemia
  • Myeloproliferative neoplasms
  • Research
Read more
Illustration of a microscope, test tubes, and clipboard

Drug discovery has remarkable potential for high-risk childhood leukaemia

Dr Michelle Henderson's research is laying the groundwork to develop a promising new therapy for infant ALL.

  • Acute lymphoblastic leukaemia
  • Research
Read more
Dr Michelle Henderson in the lab

From PhD in Melbourne to postdoc in New York

New York-based, Aussie researcher Matt Witkowski has his sights set on improving the effectiveness of CAR T-cell therapy.

  • Acute lymphoblastic leukaemia
  • Research
Read more
Matthew Witkowski

Research aims to improve QOL by decreasing treatment toxicity

Kate Vandyke is leading exciting research examining whether a new inhibitor can be used to prepare myeloma patients for therapies and increase their efficacy.

  • Myeloma
  • Research
Read more
Kate van Dyke

Clinical trials critical to finding curative therapies for MPN

Professor David Ross discusses the "massive explosion" of recent clinical trial activity in MPN.

  • Myeloproliferative neoplasms
  • Research
Read more
Dr David Ross and others in Tokyo

Improving outcomes for Australians with an MPN 

Dr Liesl Butler is investigating the gene mutations and biological pathways that lead to the development of MPN.

  • Myeloproliferative neoplasms
  • Research
Read more
Gene

Q&A: Dr Peter Diamond – our head of research

Head of the Leukaemia Foundation’s National Research Program, Dr Peter Diamond discusses his role, priorities for the program, and exciting breakthroughs coming up in blood cancer research. 

  • Research
Read more
Dr Peter Diamond

Searching for “more effective and gentler” therapies for AML

The Professor of Harvard University’s Department of Stem Cell and Regenerative Biology spoke with us about why he chose this line of work, and his research objectives.

  • Acute myeloid leukaemia
  • Research
Read more
Dr David Scadden at a lab meeting at Harvard University

 Adding the microenvironment to the AML therapy mix improves efficacy   

Associate Professor Ingrid Wrinkler's findings have "opened up a whole new field".

  • Acute myeloid leukaemia
  • Research
Read more
Ingrid Winker and Valerie Barbier

Leukaemia Foundation invests almost $3m in innovative AML research

Seven research projects that are part of the National Research Program focus on better understanding and treating acute myeloid leukaemia (AML). 

  • Acute myeloid leukaemia
  • Research
Read more
Dr Laura Bray

Understanding MDS and the biological processes driving treatment response

Dr Steven Lane hopes to understand how myelodysplasia (MDS) forms from normal cells.

  • Myelodysplastic syndromes
  • Research
Read more
Steven Lane in the lab

What’s CAR T-cell therapy?

Dr Bruce Levine explains how it works and why.

  • Research
  • Treatments and side-effects
Read more
Bruce Levine

Q&A: Professor Timothy Hughes – Part 1

We spoke to world leader in CML research, Professor Timothy Hughes.

  • Chronic myeloid leukaemia
  • Research
Read more
Timothy Hughes presenting

Q&A: Professor Timothy Hughes – Part 2

Here is part two of our interview with world leader in CML research, Professor Timothy Hughes.

  • Chronic myeloid leukaemia
  • Research
Read more
Timothy Hughes

“The biggest discoveries come from basic biological research”

Rebecca's research work is looking at different pathways of NK cells in acute myeloid leukaemia.

  • Acute myeloid leukaemia
  • Research
Read more
Rebecca Delconte

Addressing knowledge gaps in immunoglobulin therapy

Dr Khai Li Chai is working to improve the prevention and treatment of infection in blood cancer patients with antibody replacement therapy.

  • Chronic lymphocytic leukaemia
  • Myeloma
  • Non-Hodgkin lymphoma
  • Research
  • Treatments and side-effects
Read more
Khai Li Chai

Better outcomes for aplastic anaemia and bone marrow failure syndromes

Describing, understanding and improving the diagnosis of aplastic anaemia and bone marrow failure syndromes.

  • Blood disorders
  • Research
Read more
Dr Lucy Fox

Multi-Million Dollar Research Program to fight GVHD

There’s an urgent need for new approaches to better prevent and treat GVHD.

  • Research
  • Treatments and side-effects
Read more
Professor David Gottlieb

New research breakthroughs

Researchers such Dr Siok Tey are dedicated to driving rapid advancements in treatments, discovering new therapies, and launching innovative clinical trials.

  • Hodgkin lymphoma
  • Research
Read more
Dr Siok Tey in the lab

Leukaemia Foundation invests in innovative MDS research 

Better understanding and treating MDS is the focus of five new research projects that are part of the Leukaemia Foundation’s National Research Program.

  • Myelodysplastic syndromes
  • Research
Read more
Illustration of a microscope, test tubes, and clipboard

Unlocking the key to understanding cell death 

PhD student Elizabeth is investigating how mutations in a tumour suppressor protein, known as p53, contribute to the development of lymphoma.

  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Research
Read more
Elizabeth Lieschke